Login / Signup

Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID-19.

Asha C BowenSteven Y C TongJoshua Saul Davis
Published in: The Medical journal of Australia (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • clinical trial
  • quality improvement
  • respiratory syndrome coronavirus
  • phase ii
  • open label
  • double blind
  • phase iii